D-0950-2016 Class III Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0950-2016 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Mar 31, 2016 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 6, 2018). Affected quantity: 62,800 Tubes.

Recall details

Product Type
Drugs
Report Date
Jun 8, 2016
Initiation Date
Mar 31, 2016
Termination Date
Jun 6, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
62,800 Tubes

Product description

¿Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-5205-5.

Reason for recall

Subpotent Drug

Distribution pattern

U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA

Code information

Lot # A5192-18338, Expiry: 12/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0950-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0950-2016. Report a data issue: hello@regdatalab.com.